Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIPIOJOINT-2
2023-508844-24-00Phase 3Authorised
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ethiodized oil in knee osteoarthritis (OA) (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Change in VAS pain score at 3 months. Planned start May 2024; status: authorised.
02
Drugs
ethiodized oil
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2023-508844-24-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-508844-24-00.